RK

Raju Kumar Singh

Active Director Director DIN 11569787
DIN 11569787 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Raju Kumar Singh

Data last updated:

Raju Kumar Singh is a Director at Pipro Pharma Private Limited (since 2026).

DIN 11569787
Primary Designation Director
First Appointment 25 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pipro Pharma Private Limited U46497BR2026PTC082977
Director25 Feb 20262026Active

Board colleagues of Raju Kumar Singh

NameDINCompanyDesignation
Piyush Raj11184980Pipro Pharma Private LimitedDirector
Rajan Kumar Singh03067497Pipro Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pipro Pharma Private Limited
Premium access

Shareholding and investment profile for Raju Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Kumar Singh

Raju Kumar Singh currently holds 1 directorship: Pipro Pharma Private Limited (Director, since 25 Feb 2026).

Raju Kumar Singh was first appointed on 25 Feb 2026 as Director at Pipro Pharma Private Limited.

The current boards of Raju Kumar Singh's companies include Piyush Raj (Pipro Pharma Private Limited), Rajan Kumar Singh (Pipro Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available